Synergism between fluoxetine and the mGlu2/3 receptor agonist, LY379268, in an in vitro model for antidepressant drug-induced neurogenesis

Neuropharmacology

Volumn 54, Issue 2, 2008, Pages 428-437

  Matrisciano, F ^a,b   Zusso, M ^c   Panaccione, I ^a   Turriziani, B ^a   Caruso, A ^a   Iacovelli, L ^a   Noviello, L ^a   Togna, G ^a   Melchiorri, D ^a   Debetto, P ^c   Tatarelli, R ^b   Battaglia, G ^d   Nicoletti, F ^a,d   Giusti, P ^c   Girardi, P ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d IRCCS NEUROMED   (Italy)

Author keywords

Cell proliferation; Cerebellar progenitors; Fluoxetine; mGlu3 receptors; Neurogenesis

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; 8 BROMO CYCLIC AMP; ADENYLATE CYCLASE; FLUOXETINE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; SEROTONIN 1A RECEPTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEPRESSION; DRUG MECHANISM; DRUG POTENTIATION; GRANULE CELL; MONOTHERAPY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STEM CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AMINO ACIDS; ANIMALS; ANIMALS, NEWBORN; ANTIDEPRESSIVE AGENTS; BICYCLO COMPOUNDS, HETEROCYCLIC; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CEREBELLUM; CYCLIC AMP; DNA, COMPLEMENTARY; DRUG SYNERGISM; FLUOXETINE; IMMUNOHISTOCHEMISTRY; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROTONIN UPTAKE INHIBITORS; STEM CELLS;

EID: 38349082456     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.10.020     Document Type: Article

References (46)

1. Angelucci F., Brene S., and Mathe A.A. BDNF in schizophrenia, depression and corresponding animal models. Mol. Psychiatry 10 (2005) 345-352
2. Barbon A., Popoli M., La Via L., Moraschi S., Vallini I., Tardito D., Tiraboschi E., Musazzi L., Giambelli R., Pennarelli M., Racagni G., and Barlati S. Regulation of editing and expression of glutamate alpha-amino-propionic-acid (AMPA)/kainate receptors by antidepressant drugs. Biol. Psychiatry 59 (2006) 713-720
3. Battaglia G., Busceti L.C., Molinaro G., Biagioni F., Storto M., Fornai F., Nicoletti F., and Bruno V. Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. J. Neurosci. 24 (2004) 828-835
4. Belozertseva I.V., Kos T., Popik P., Danysz W., and Bespalov A.Y. Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests. Eur. Neuropsychopharmacol. 17 (2007) 172-179
5. Bohm C., Newrzella D., Herberger S., Schramm N., Eisenhardt G., Schenk V., Sonntag-Buck V., and Sorgenfrei O. Effects of antidepressant treatment on gene expression profile in mouse brain: cell type-specific transcription profiling using laser microdissection and microarray analysis. J. Neurochem. 97 (2006) 44-49
6. Brazel C.Y., Nunez J.L., Yang Z., and Levison S.W. Glutamate enhances survival and proliferation of neural progenitors derived from the subventricular zone. Neuroscience 131 (2005) 55-65
7. Caricasole A., Bruno V., Cappuccio I., Melchiorri D., Copani A., and Nicoletti F. A novel rat gene encoding a Humanin-like peptide endowed with broad neuroprotective activity. FASEB J 16 (2002) 1331-1333
8. Chaki S., Yoshikawa R., Hirota S., Shimazaki T., Maeda M., Kawashima N., Yoshimizu T., Yasuhara A., Sakagami K., Okuyama S., Nakanishi S., and Nakazato A. MSG0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity. Neuropharmacology 46 (2004) 457-467
9. Chang F., Steelman L.S., Shelton J.G., Lee J.T., Navolanic P.M., Blalock W.L., Franklin R., and McCubrey J.A. Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway. Int. J. Oncol. 22 (2002) 469-480
10. Cryan J.F., Kelly P.H., Neijt H.C., Sansig G., Flor P.J., and van Der Putten H. Antidepressant and anxiolytic-like effects in mice lacking the group III metabotropic glutamate receptor mGluR7. Eur. J. Neurosci. 17 (2003) 2409-2417
11. De Blasi A., Conn P.J., Pin J.P., and Nicoletti F. Molecular determinants of metabotropic glutamate receptor signaling. Trends Pharmacol. Sci. 22 (2001) 114-120
12. Di Giorgi-Gerevini V., Melchiorri D., Battaglia G., Ricci-Vitiani L., Ciceroni C., Buscati C.L., Biagioni F., Iacovelli L., Canudas A.M., Parati E., De Maria R., and Nicoletti F. Endogenous activation of metabotropic glutamate receptors supports the proliferation and survival of neural progenitor cells. Cell Death Differ. 12 (2005) 1124-1133
13. Duman R.S., Nakagawa S., and Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 25 (2001) 836-844
14. Huzarska M., Zielinski M., and Herman Z.S. Repeated treatment with antidepressants enhances dopamine D1 receptor gene expression in the rat brain. Eur. J. Pharmacol. 532 (2006) 208-213
15. Iacovelli L., Capobianco L., Iula M., Di Giorgi Gerevini V., Picascia A., Blahos J., Melchiorri D., Nicoletti F., and De Blasi A. Regulation of mGlu4 metabotropic glutamate receptor signaling by type-2 G-protein coupled receptor kinase (GRK2). Mol. Pharmacol. 65 (2004) 1103-1110
16. Kniazeff J., Bessis A.S., Maurel D., Ansanov H., Prézeau L., and Pin J.P. Closed state of both binding domains of homodimeric mGlu receptors is required for full activity. Nat. Struct. Mol. Biol. 11 (2004) 706-713
17. Li X., Need A.B., Baez M., and Witkin J.M. Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice. J. Pharmacol. Exp. Ther. 319 (2006) 254-259
18. Malberg J.E., Eisch A.J., Nestler E.J., and Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 24 (2000) 9104-9110
19. Manev H., Uz T., Smalheiser N.R., and Manev R. Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro. Eur. J. Pharmacol. 411 (2001) 67-70
20. Martinez-Turrillas R., Frechilla D., and Del Rio J. Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus. Neuropharmacology 43 (2002) 1230-1237
21. Matrisciano F., Storto M., Ngomba R.T., Cappuccio I., Caricasole A., Scaccianoce S., Riozzi B., Melchiorri D., and Nicoletti F. Imipramine treatment up-regulates the expression and function of mGlu2/3 metabotropic glutamate receptors in the rat hippocampus. Neuropharmacology 42 (2002) 1008-1015
22. Matrisciano F., Scaccianoce S., Del Bianco P., Panaccione I., Canudas A.M., Battaglia G., Riozzi B., Ngomba R., Molinaro G., Tatarelli R., Melchiorri D., and Nicoletti F. Metabotropic glutamate receptors and neuroadaptation to antidepressants: imipramine-induced down-regulation of β-adrenergic receptors in mice treated with metabotropic glutamate 2/3 receptor ligands. J. Neurochem. 93 (2005) 1345-1352
23. Matrisciano F., Panaccione I., Zusso M., Giusti P., Tatarelli R., Iacovelli L., Mathee A.A., Gruber D.H., Nicoletti F., and Girardi P. Group-II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten the latency of antidepressant medication?. Mol. Psychiatry 12 (2007) 704-706
24. Mercier G., Lennon A.M., Renouf B., Dessouroux A., Ramauge M., Courtin F., and Pierre M. MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes. J. Mol. Neurosci. 24 (2004) 207-216
25. Molina-Hernandez M., Tellez-Alcantara N.P., Perez-Garcia J., Olivera-Lopez J.I., and Jaramillo M.T. Antidepressant-like and anxiolytic-like actions of the mGlu5 receptor antagonist MTEP, microinjected into lateral septal nuclei of male Wistar rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 30 (2006) 1129-1135
26. Nakagawa S., Kim J.E., Lee R., Malberg J.E., Chen J., Steffen C., Zhang Y.J., Nestler E.J., Duman R.S., et al. Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. J. Neurosci. 22 (2002) 3673-3682
27. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science 258 (1992) 597-603
28. Nicot A., Lelievre V., Tam J., Waschek J.A., and DiCicco-Bloom E. Pituitary adenylate cyclase-activating polypeptide and sonic hedgehog interact to control cerebellar granule precursor cell proliferation. J. Neurosci. 22 (2002) 9244-9254
29. Palucha A., Tatarczynska E., Branski P., Szewczyk B., Wieronska J.M., Klak K., Chojnacka-Wòjcik E., Nowak G., and Pilc A. Group III mGlu receptor antagonists produce anxiolytic- and antidepressant-like effects after central administration in rats. Neuropharmacology 46 (2004) 151-159
30. Palucha A., Branski P., Szewczyk B., Wieronska J.M., Klak K., and Pilc A. Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist. Pharmacol. Biochem. Behav. 81 (2005) 901-906
31. Paris M., Wang W.H., Shin M.H., Franklin D.S., and Andrisani O.M. Homeodomain transcription factor Phox2a, via cyclic AMP-mediated activation, induces p27Kip1 transcription, coordinating neural progenitor cell cycle exit and differentiation. Mol. Cell. Biol. 26 (2006) 8826-8839
32. Pin J.P., and Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34 (1995) 1-26
33. Rihmer Z., and Gonda X. Suicide behaviour in patients treated with antidepressants. Neuropsychopharmacol. Hung 8 (2006) 13-16
34. Roelen B.A., Van Eijk M.J., Van Rooijen M.A., Bevers M.M., Larson J.H., Lewin H.A., and Mummery C.L. Molecular cloning, genetic mapping and developmental expression of a bovine transforming growth factor beta (TGF-beta) type I receptor. Mol. Reprod. Dev. 49 (1998) 1-9
35. Rogoz Z., Skuza G., and Legutko B. Repeated treatment with mirtazepine induces brain-derived neurotrophic factor gene expression in rats. J. Physiol. Pharmacol. 56 (2005) 661-671
36. Russo-Neustadt A.A., and Chen M.J. Brain-derived neurotrophic factor and antidepressant activity. Curr. Pharm. Des 11 (2005) 1495-1510
37. Santarelli L., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., Weisstaub N., Lee J., Duman R., Arancio O., Belzung C., and Hen R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301 (2003) 805-809
38. Schoepp D.D., Jane D.E., and Monn J.A. Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology 38 (1999) 1431-1476
39. Swanson C.J., Bures M., Johnson M.P., Linden A.M., Monn J.A., and Schoepp D.D. Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat. Rev. Drug Discov. 4 (2005) 131-144
40. Tardito D., Perez J., Tiraboschi E., Musazzi L., Racagni G., and Popoli M. Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol. Rev. 58 (2006) 115-134
41. Tatarczynska E., Klodzinska A., Chojnacka-Wojcik E., Palucha A., Gasparini F., Kuhn R., and Pilc A. Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. Br. J. Pharmacol. 132 (2001) 1423-1430
42. Tatarczynska E., Palucha A., Szewczyk B., Chojnacka-Wojcik E., Wieronska J., and Pilc A. Anxiolytic- and antidepressant-like effects of group III metabotropic glutamate agonist (1S, 3R, 4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (ACPT-I) in rats. Pol. J. Pharmacol. 54 (2002) 707-710
43. Vinet J., Carra S., Blom J.M., Brunello N., Barden N., and Tascedda F. Chronic treatment with desipramine and fluoxetine modulate BDNF, CaMKKalpha and CaMKKbeta mRNA levels in the hippocampus of transgenic mice expressing antisense RNA against the glucocorticoid receptor. Neuropharmacology 47 (2004) 1062-1069
44. Wieronska J.M., Szewczyk B., Branski P., Palucha A., and Pilc A. Antidepressant-like effect of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist in the olfactory bulbectomized rats. Amino Acids 23 (2002) 213-216
45. Yoshimizu T., and Chaki S. Increased cell proliferation in the adult mouse hippocampus following chronic administration of group II metabotropic glutamate receptor antagonist, MGS0039. Biochem. Biophys. Res. Commun. 315 (2004) 493-496
46. Zusso M., Debetto P., Guidolin D., and Giusti P. Cerebellar granular cell cultures as an in vitro model for antidepressant drug-induced neurogenesis. Crit. Rev. Neurobiol. 16 (2004) 59-65